1 / 1

Role of Stenting in Acute MI: PAMI Stent Pilot Trial

Role of Stenting in Acute MI: PAMI Stent Pilot Trial. PTCA Stent PTCA Stent n=290 n=292 n=146 n=147 1-Month death (%) 1.7 5.2 † 1.4 1.4 6-Month MACE (%) 18.4 13.8 15.5 10.6 6-Month death (%) 2.1 6.0 † 2.8 1.4 6-Month TVR (%) 15.9 6.6 ‡ 12.2 9.2

raheem
Download Presentation

Role of Stenting in Acute MI: PAMI Stent Pilot Trial

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Role of Stenting in Acute MI: PAMI Stent Pilot Trial PTCA Stent PTCA Stent n=290 n=292 n=146 n=147 1-Month death (%) 1.7 5.2† 1.4 1.4 6-Month MACE (%) 18.4 13.8 15.5 10.6 6-Month death (%) 2.1 6.0 † 2.8 1.4 6-Month TVR (%) 15.9 6.6‡ 12.2 9.2 6-Month restenosis (%) 37.9 21.0 ‡ 25.3 23.1 PTCA Stent PTCA Stent n=290 n=292 n=146 n=147 1-Month death (%) 1.7 5.2† 1.4 1.4 6-Month MACE (%) 18.4 13.8 15.5 10.6 6-Month death (%) 2.1 6.0 † 2.8 1.4 6-Month TVR (%) 15.9 6.6‡ 12.2 9.2 6-Month restenosis (%) 37.9 21.0 ‡ 25.3 23.1 TIMI 0-1 TIMI 2-3 • MACE, major adverse cardiac events; TVR, target vessel revascularization. †P < 0.05, ‡ P <0.0001 Adapted from Lansky et al. J Am Coll Cardiol. 1999;33 (Suppl A):368A.

More Related